Biozone Pharmaceuticals

About:

Biozone Pharmaceuticals develops pharmaceuticals, cosmetics and beauty products for third-party contract manufacturing customers.

Website: http://www.biozonelabs.com

Top Investors: MusclePharm

Description:

BioZone Pharmaceuticals (OTC BB: BZNE) is a public pharmaceutical company that specializes in drug development, manufacturing, and marketing. The company has developed proprietary drug delivery technology that has enabled and revolutionized the administration of drugs that are difficult to formulate. The application of this technology allows the company to pursue reformulation of generic drugs and pursue a low-risk regulatory pathway for NDA approval. Additionally, BioZone provides oral, topical, and injectable drug products for anesthesia, infectious diseases, metabolic diseases, and oncology, and offers a unique line of dermatology products for a variety of dermatological diseases. Flagship products include P&S Liquid and Shampoo and the GlyDerm dermatological care line. The company is currently looking to agressively expand in both size and product line.

Total Funding Amount:

$9.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pittsburg, California, United States

Founded Date:

2006-12-04

Contact Email:

info(AT)biozonelabs.com

Founders:

Brian Keller, Daniel Fisher

Number of Employees:

11-50

Last Funding Date:

2014-01-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai